Varun Jaiswal

Dr. Varun Jaiswal

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2014 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
HPHarun M. Patel
Harun M. Patel
MNMalleshappa N. Noolvi
Malleshappa N. Noolvi
PSPoonam Sharma
Poonam Sharma
VJVarun Jaiswal
Varun Jaiswal
SBSumit Bansal
Sumit Bansal
VBVarun Bhardwaj
Varun Bhardwaj

1 June 2021 in Primary Care Diabetes
Verified
Journal Article
Closed access
VJVarun Jaiswal
Varun Jaiswal
ANAnjli Negi
Anjli Negi
TPTarun Pal
Tarun Pal

1 July 2013 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
VJVarun Jaiswal
Varun Jaiswal
SCSree Krishna Chanumolu
Sree Krishna Chanumolu
AGAnkit Gupta
Ankit Gupta
RCRajinder S Chauhan
Rajinder S Chauhan
CRChittaranjan Rout
Chittaranjan Rout
Background: Subunit vaccines based on recombinant proteins have been effective in preventing infectious diseases and are expected to meet the demands of future vaccine development. Computational approach, especially reverse vaccinology (RV) method has enormous potential for identification of protein vaccine candidates (PVCs) from a proteome. The existing protective antigen prediction software and web servers have low prediction accuracy leading to limited applications for vaccine development. Besides machine learning techniques, those software and web servers have considered only protein’s adhesin-likeliness as criterion for identification of PVCs. Several non-adhesin functional classes of proteins involved in host-pathogen interactions and pathogenesis are known to provide protection against bacterial infections. Therefore, knowledge of bacterial pathogenesis has potential to identify PVCs. Results: A web server, Jenner-Predict, has been developed for prediction of PVCs from proteomes of bacterial pathogens. The web server targets host-pathogen interactions and pathogenesis by considering known functional domains from protein classes such as adhesin, virulence, invasin, porin, flagellin, colonization, toxin, choline-binding, penicillin-binding, transferring-binding, fibronectin-binding and solute-binding. It predicts non-cytosolic proteins containing above domains as PVCs. It also provides vaccine potential of PVCs in terms of their possible immunogenicity by comparing with experimentally known IEDB epitopes, absence of autoimmunity and conservation in different strains. Predicted PVCs are prioritized so that only few prospective PVCs could be validated experimentally. The performance of web server was evaluated against known protective antigens from diverse classes of bacteria reported in Protegen database and datasets used for VaxiJen server development. The web server efficiently predicted known vaccine candidates reported from Streptococcus pneumoniae and Escherichia coli proteomes. The Jenner-Predict server outperformed NERVE, Vaxign and VaxiJen methods. It has sensitivity of 0.774 and 0.711 for Protegen and VaxiJen dataset, respectively while specificity of 0.940 has been obtained for the latter dataset. Conclusions: Better prediction accuracy of Jenner-Predict web server signifies that domains involved in host-pathogen interactions and pathogenesis are better criteria for prediction of PVCs. The web server has successfully predicted maximum known PVCs belonging to different functional classes. Jenner-Predict server is freely accessible at http://117.211.115.67/vaccine/home.html

1 May 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSSharad Kumar Suthar
Sharad Kumar Suthar
VJVarun Jaiswal
Varun Jaiswal
SLSandeep Lohan
Sandeep Lohan
SBSumit Bansal
Sumit Bansal
ACAnil Chaudhary
Anil Chaudhary
AJAlex Joesph
Alex Joesph

1 November 2016 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
TPTarun Pal
Tarun Pal
VJVarun Jaiswal
Varun Jaiswal
RCRajinder S. Chauhan
Rajinder S. Chauhan

16 May 2024 in Redox Biology
Verified
Journal Article
Open access
S.Sanjay ..
Sanjay ..
Sood SoodSood Sood
Sood Sood
VJVarun Jaiswal
Varun Jaiswal
Sung-Ung KangSung-Ung Kang
Sung-Ung Kang
MPMiey Park
Miey Park
Hae-Jeung LeeHae-Jeung Lee
Hae-Jeung Lee
Astrocytes are the major glial cells in the human brain and provide crucial metabolic and trophic support to neurons. The amyloid-β peptide (Aβ) alter the morphological and functional properties of astrocytes and induce inflammation and calcium dysregulation, contributing to Alzheimer's disease (AD) pathology. Recent studies highlight the role of Toll-like receptor (TLR) 4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling in inflammation. Reactive oxygen species (ROS) generated due to Aβ, induce apoptosis in the brain cells worsening AD progression. Astrocytic cell surface receptors, such as purinergic receptors (P2Y1 and P2Y2), metabotropic glutamate receptor (mGLUR)5, α7 nicotinic acetylcholine receptor (α7nAChR), and N-methyl-d-aspartate receptors (NMDARs), have been suggested to interact with inositol trisphosphate receptor (IP3R) on the endoplasmic reticulum (ER) to induce Ca2+ movement from ER to cytoplasm, causing Ca2+ dysregulation. We found that the citrus flavonoid nobiletin (NOB) protected primary astrocytes from Aβ42-induced cytotoxicity and inhibited TLR4/NF-κB signaling in Aβ42-induced primary rat astrocytes. NOB was found to regulate Aβ42-induced ROS levels through Keap1-Nrf2 pathway. The receptors P2Y1, P2Y2, mGLUR5, α7nAChR, and NMDARs induced intracellular Ca2+ levels by activating IP3R and NOB regulated them, thereby regulating intracellular Ca2+ levels. Molecular docking analysis revealed a possible interaction between NOB and IP3R in IP3R regulation. Furthermore, RNA sequencing revealed various NOB-mediated biological signaling pathways, such as the AD-presenilin, AD-amyloid secretase, and Wnt signaling pathway, suggesting possible neuroprotective roles of NOB. To conclude, NOB is a promising therapeutic agent for AD and works by modulating AD pathology at various levels in Aβ42-induced primary rat astrocytes.